SPOTLIGHT -
EP. 1: New OS Data in Treatment for Nonmetastatic CRPC
EP. 2: Apalutamide in Treating Nonmetastatic CRPC
EP. 3: The SPARTAN Trial Interim Analysis
EP. 4: The PROSPER and ARAMIS Trials in CRPC
EP. 5: The Impact of Recently Approved AR-Targeted Therapy
EP. 6: The Future of Nonmetastatic CRPC Management
EP. 7: The STAMPEDE Trial Long Term Follow-Up Data
EP. 8: The Approval of Apalutamide for Metastatic CSPC
EP. 9: The Role of Enzalutamide in Treating Metastatic CSPC
EP. 10: Metastatic CSPC: Toxicity Management & Future Treatment
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
